Narayan Acharya

About

I hold a Ph.D. in Toxicology with research experience in molecular toxicology, cancer biology, and analytical toxicology. I am familiar with key molecular biology skills, including flow cytometry analysis, ELISA, multiplex assay, cytotoxicity assays, soft agar assays, Western blotting, qRT-PCR, and the isolation, quantification, and quality assessment of RNA, DNA, and protein. Also familiar with single-cell and bulk RNA sample preparation, and sequencing data analysis and MS-MS-based proteomics. Additionally, I am familiar with both theoretical and practical methods of analytical instruments, including mass spectrometry (GC-MS and LC-MS).

Employment

• The University of Texas at Austin Postdoctoral Fellow
  2021 - Present

Education

• Texas Tech University PhD
  2016 - 2021
• Institute of Agriculture and Animal Science (IAAS) DVM
  2006 - 2011

Projects & Funding

Projects & funding information is unavailable.

Publications (21)

• MEHP exposure damages the basement membrane by suppressing the expression of its constituent proteins in peritubular myoid cells of the rat testis
  Toxicological Sciences 2026 DOI: 10.1093/toxsci/kfag070
  +Save
• Why did rabies control fail in low-income and middle-income countries?
  The Lancet Microbe 2025 DOI: 10.1016/j.lanmic.2025.101259
  +Save
• Peritubular Myoid Cells of the Testis Produce Monocyte Chemotactic Protein 1 Upon Direct Exposure to Mono-(2-Ethylhexyl) Phthalate Through the IL-1 Signaling Pathway
  Toxicology 2025 DOI: 10.1016/j.tox.2025.154118
  +Save
• Epigenetic therapeutics attenuate kidney injury and fibrosis by restoring the expression of epigenetically reprogrammed fibrogenic genes and signaling pathways
  European Journal of Pharmaceutical Sciences 2025 DOI: 10.1016/j.ejps.2024.106977
  +Save
• Possible Consequences of Climate Change on Survival, Productivity and Reproductive Performance, and Welfare of Himalayan Yak (Bos grunniens)
  Veterinary Sciences 2022 DOI: 10.3390/vetsci9080449
  +Save
• Recent advances in the molecular basis of chemotherapy resistance and potential application of epigenetic therapeutics in chemorefractory renal cell carcinoma
  WIREs Mechanisms of Disease 2022 DOI: 10.1002/wsbm.1575
  +Save
• Differential sensitivity of renal carcinoma cells to doxorubicin and epigenetic therapeutics depends on the genetic background
  Molecular and Cellular Biochemistry 2021 DOI: 10.1007/s11010-021-04076-7
  +Save
• PPR control program in Nepal: What next?
  VirusDisease 2020 DOI: 10.1007/s13337-020-00572-4
  +Save
• Establishment and recent surge in spatio-temporal spread of dengue in Nepal
  Emerging Microbes & Infections 2020 DOI: 10.1080/22221751.2020.1740062
  +Save
• Obesogenic Toxicants in Breast Milk of Lactating Women: Investigation of a Risk Factor for Childhood Obesity
  Biological Research For Nursing 2020 DOI: 10.1177/1099800420909151
  +Save